Business Description
Zentek Ltd
NAICS : 339114
SIC : 3912
ISIN : CA98943A1012
Description
Zentek Ltd is an IP development and commercialization company focused on next-gen healthcare solutions in the areas of prevention, detection, and treatment.?It is focused on commercializing ZENGuard, a patent-pending coating with 99% antimicrobial activity, including against COVID-19,?and the potential to use?similar?compounds?as pharmaceutical products?against infectious diseases.
Financial Strength
6/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 2.83 | |||||
Equity-to-Asset | 0.89 | |||||
Debt-to-Equity | 0.06 | |||||
Debt-to-EBITDA | -0.11 | |||||
Piotroski F-Score | 2/9 | |||||
Altman Z-Score | 27.87 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | -35.7 | |||||
3-Year EPS without NRI Growth Rate | -33.1 | |||||
3-Year FCF Growth Rate | -51.2 | |||||
3-Year Book Growth Rate | -14.4 |
Momentum Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 34.1 | |||||
9-Day RSI | 38.9 | |||||
14-Day RSI | 41.59 | |||||
6-1 Month Momentum % | -7.83 | |||||
12-1 Month Momentum % | -25.35 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 3.44 | |||||
Quick Ratio | 2.65 | |||||
Cash Ratio | 1.94 | |||||
Days Inventory | 2827.01 | |||||
Days Sales Outstanding | 471.46 | |||||
Days Payable | 872.52 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -5.4 | |||||
Shareholder Yield % | 0.25 |
Profitability Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | -1020 | |||||
Operating Margin % | -39926.67 | |||||
Net Margin % | -39013.33 | |||||
FCF Margin % | -28815 | |||||
ROE % | -46.42 | |||||
ROA % | -42.09 | |||||
ROIC % | -62.17 | |||||
ROC (Joel Greenblatt) % | -67.1 | |||||
ROCE % | -45.19 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PB Ratio | 6.8 | |||||
Price-to-Tangible-Book | 7.04 | |||||
EV-to-EBIT | -11.52 | |||||
EV-to-EBITDA | -12.16 | |||||
EV-to-Revenue | 4491.83 | |||||
EV-to-FCF | -16.1 | |||||
Price-to-Net-Current-Asset-Value | 30.5 | |||||
Price-to-Net-Cash | 91.5 | |||||
Earnings Yield (Greenblatt) % | -8.68 | |||||
FCF Yield % | -6.11 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Zentek Ltd Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil €) | 0.02 | ||
EPS (TTM) (€) | -0.083 | ||
Beta | -0.08 | ||
Volatility % | 44.36 | ||
14-Day RSI | 41.59 | ||
14-Day ATR (€) | 0.032056 | ||
20-Day SMA (€) | 0.9825 | ||
12-1 Month Momentum % | -25.35 | ||
52-Week Range (€) | 0.91 - 1.48 | ||
Shares Outstanding (Mil) | 100.76 |
Piotroski F-Score Details
Year:
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 2 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Zentek Ltd Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Zentek Ltd Stock Events
Event | Date | Price(€) | ||
---|---|---|---|---|
No Event Data |
Zentek Ltd Frequently Asked Questions
What is Zentek Ltd(FRA:ZAY0)'s stock price today?
The current price of FRA:ZAY0 is €0.91. The 52 week high of FRA:ZAY0 is €1.48 and 52 week low is €0.91.
When is next earnings date of Zentek Ltd(FRA:ZAY0)?
The next earnings date of Zentek Ltd(FRA:ZAY0) is 2024-08-09 Est..
Does Zentek Ltd(FRA:ZAY0) pay dividends? If so, how much?
Zentek Ltd(FRA:ZAY0) does not pay dividend.
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |